Pacific Biosciences of California, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+13.8% +$5M
$45M
Cost of Revenue↓-3.7% -$1M
$28M
Gross Profit↑+64.7% +$7M
$17M
R&D↓-16.7% -$5M
$23M
SG&A↓-18.2% -$8M
$34M
D&A↓-3.7% -$106K
$3M
Operating Income↑+39.3% +$25M
$-39M
EBITDA↓-3.7% -$106K
$3M
Interest Expense↓-36.9% -$1M
$2M
Other Income/Expense↓-56.5% -$4M
$3M
Pretax Income↑+38.1% +$23M
$-38M
Tax Provision
$383K
Net Income↑+37.4% +$23M
$-38M
Gross Margin↑+11.5pts
37.1%
Operating Margin↑+59.2pts
-101.1%
Net Margin↑+53.1pts
-98.9%
Effective Tax Rate↓-1.0pts
-1.0%
ETR (Continuing Operations)↑+0.0pts
-0.1%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-0.3pts
0.1%
ETR Foreign Differential (pp)↑+0.0pts
-0.1%
Operating Lease Cost↓-53.1% -$5M
$5M
Revenue YoY Variation↑+74.4pts
13.8%
Income YoY Variation↑+17.0pts
39.3%
Revenue QoQ Variation↑+18.0pts
16.1%
Income QoQ Variation↓-50.2pts
13.3%